@misc{indiciae13707526c031,
  title = {CREBBP/EP300 mutation is associated with poor outcome in HNSCC and targetable with synthetic cytotoxicity.},
  author = {Kumar, M. and Molkentine, D. and Molkentine, J. and Bridges, K. and Xie, T. and Yang, L. and Gao, M. and Frederick, M. J. and Seth, S. and Abdelhakiem, M. and Johnson, F. M. and Wang, J. and Shen, L. and Heffernan, T. and Sheth, A. and Ferris, R. and Myers, J. N. and Pickering, C. R. and Skinner, H. D.},
  year = {2020},
  doi = {10.1101/2020.04.10.028217},
  url = {https://www.biorxiv.org/content/10.1101/2020.04.10.028217v1},
  note = {Source identifier: 10.1101/2020.04.10.028217}
}